Theriva Biologics Inc. Cash Flow-to-Debt Ratio
Theriva Biologics Inc. cash flow-to-debt ratio. Theriva Biologics Inc. (TOVX) has a Cash Flow-to-Debt Ratio of -0.11x as of March 2026, meaning its operating cash flow of $-2.46 Million could theoretically repay 0% of its total liabilities ($22.85 Million) in one year. Check cash flow quality index of Theriva Biologics Inc. to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Theriva Biologics Inc. (1993–2025)
Cash flow-to-debt ratio of Theriva Biologics Inc. from 1993 to 2025. Historical debt coverage capacity for Theriva Biologics Inc. across 31 annual periods. Check TOVX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Theriva Biologics Inc. Cash Flow-to-Debt Ratio by Year (1993–2025)
Theriva Biologics Inc. cash flow-to-debt ratio by year from 1993 to 2025. Year-by-year debt coverage analysis for Theriva Biologics Inc.. For the full cash flow conversion analysis, see Theriva Biologics Inc. cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.73x | $-16.67 Million | $22.86 Million | ▲ +29.9% |
| 2024 | -1.04x | $-16.94 Million | $16.29 Million | ▲ +15.0% |
| 2023 | -1.22x | $-19.00 Million | $15.52 Million | ▼ -10.9% |
| 2022 | -1.10x | $-19.08 Million | $17.30 Million | ▲ +57.6% |
| 2021 | -2.60x | $-12.89 Million | $4.96 Million | ▲ +32.6% |
| 2020 | -3.86x | $-12.17 Million | $3.15 Million | ▼ -59.9% |
| 2019 | -2.41x | $-13.87 Million | $5.75 Million | ▲ +48.5% |
| 2018 | -4.69x | $-17.28 Million | $3.69 Million | ▼ -416.2% |
| 2017 | -0.91x | $-20.20 Million | $22.25 Million | ▲ +34.1% |
| 2016 | -1.38x | $-27.90 Million | $20.25 Million | ▲ +43.9% |
| 2015 | -2.45x | $-38.89 Million | $15.84 Million | ▼ -46.4% |
| 2014 | -1.68x | $-16.08 Million | $9.59 Million | ▲ +77.7% |
| 2013 | -7.52x | $-7.72 Million | $1.03 Million | ▲ +66.7% |
| 2012 | -22.57x | $-8.92 Million | $395.00K | ▼ -227.4% |
| 2011 | -6.89x | $-2.88 Million | $417.00K | ▼ -222.1% |
| 2010 | -2.14x | $-1.14 Million | $532.48K | ▲ +61.0% |
| 2009 | -5.49x | $-2.92 Million | $531.43K | ▲ +29.7% |
| 2008 | -7.82x | $-4.85 Million | $620.72K | ▼ -99.6% |
| 2007 | -3.92x | $-6.61 Million | $1.69 Million | ▼ -20.6% |
| 2006 | -3.25x | $-2.37 Million | $729.02K | ▼ -542.9% |
| 2005 | -0.50x | $-1.08 Million | $2.14 Million | ▼ -46.5% |
| 2002 | -0.34x | $-5.82 Million | $16.90 Million | ▲ +52.4% |
| 2001 | -0.72x | $-8.07 Million | $11.14 Million | ▲ +24.8% |
| 2000 | -0.96x | $-5.65 Million | $5.86 Million | ▲ +73.9% |
| 1999 | -3.69x | $-16.14 Million | $4.38 Million | ▲ +56.6% |
| 1998 | -8.50x | $-18.70 Million | $2.20 Million | ▼ -267.9% |
| 1997 | -2.31x | $-6.70 Million | $2.90 Million | ▲ +57.6% |
| 1996 | -5.45x | $-6.00 Million | $1.10 Million | ▲ +70.9% |
| 1995 | -18.75x | $-7.50 Million | $400.00K | ▼ -275.0% |
| 1994 | -5.00x | $-4.50 Million | $900.00K | ▲ +71.4% |
| 1993 | -17.50x | $-3.50 Million | $200.00K | — |